Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment (2024)
Attributed to:
Underpinning UK Biomolecular Research with Next-Generation High Resolution Mass Spectrometry at the University of Edinburgh
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26434/chemrxiv-2024-d62kp
Publication URI: http://dx.doi.org/10.26434/chemrxiv-2024-d62kp
Type: Preprint